A detailed history of James Investment Research Inc transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, James Investment Research Inc holds 29,075 shares of HALO stock, worth $1.38 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
29,075
Previous 21,172 37.33%
Holding current value
$1.38 Million
Previous $1.11 Million 50.09%
% of portfolio
0.19%
Previous 0.13%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$51.3 - $64.42 $405,423 - $509,111
7,903 Added 37.33%
29,075 $1.66 Million
Q2 2024

Jul 30, 2024

BUY
$37.81 - $52.4 $800,513 - $1.11 Million
21,172 New
21,172 $1.11 Million

Others Institutions Holding HALO

About HALOZYME THERAPEUTICS, INC.


  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $6.62B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track James Investment Research Inc Portfolio

Follow James Investment Research Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of James Investment Research Inc, based on Form 13F filings with the SEC.

News

Stay updated on James Investment Research Inc with notifications on news.